Related Experiment Video
Updated: Jun 15, 2026

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3
Jason Peter Twohig1, Malcolm I Roberts, Nuria Gavalda
1Department of Infection, Immunity & Biochemistry, School of Medicine, Cardiff University, Cardiff CF14 4XN, Wales, UK.
Abstract:
Death receptor 3 is a proinflammatory member of the immunomodulatory tumor necrosis factor receptor superfamily, which has been implicated in several inflammatory diseases such as arthritis and inflammatory bowel disease. Intriguingly however, constitutive DR3 expression has been detected in the brains of mice, rats, and humans, although its neurological function remains unknown. By mapping the normal brain expression pattern of DR3, we found that DR3 is expressed specifically by cells of the neuron lineage in a developmentally regulated and region-specific pattern. Behavioral studies on DR3-deficient (DR3(ko)) mice showed that constitutive neuronal DR3 expression was required for stable motor control function in the aging adult. DR3(ko) mice progressively developed behavioral defects characterized by altered gait, dyskinesia, and hyperactivity, which were associated with elevated dopamine and lower serotonin levels in the striatum. Importantly, retrograde tracing showed that absence of DR3 expression led to the loss of corticostriatal innervation without significant neuronal loss in aged DR3(ko) mice. These studies indicate that DR3 plays a key nonredundant role in the retention of normal motor control function during aging in mice and implicate DR3 in progressive neurological disease.
Insights
Death receptor 3 (DR3) is crucial for maintaining motor control in aging mice. Its absence in neurons leads to progressive neurological defects and altered brain chemistry.
Area of Science:
- Neuroscience
- Immunology
Background:
- Death receptor 3 (DR3) is a pro-inflammatory cytokine receptor.
- DR3 is implicated in inflammatory diseases but its role in the brain is unknown.
- Constitutive DR3 expression is found in mammalian brains.
Purpose of the Study:
- To investigate the neurological function of DR3.
- To map DR3 expression in the brain.
- To determine DR3's role in motor control and aging.
Main Methods:
- Brain expression pattern mapping of DR3.
- Behavioral studies on DR3-deficient (DR3(ko)) mice.
- Neurochemical analysis of striatal dopamine and serotonin levels.
- Retrograde tracing to assess corticostriatal innervation.
Main Results:
- DR3 is expressed in neurons in a developmentally regulated, region-specific pattern.
- DR3-deficient mice exhibit progressive motor deficits (gait, dyskinesia, hyperactivity) with aging.
- Absence of DR3 leads to loss of corticostriatal innervation without neuronal death.
- Altered dopamine and serotonin levels were observed in the striatum of DR3(ko) mice.
Conclusions:
- Neuronal DR3 is essential for maintaining motor control during aging.
- DR3 plays a nonredundant role in the retention of motor function.
- DR3 deficiency may contribute to progressive neurological disorders.

